Objectives: To investigate associations between objectively measured physical activity (PA) and myopia in children.
Methods: Children from the Avon Longitudinal Study of Parents and Children (ALSPAC) were asked to wear a uniaxial accelerometer for 7 days. Measures of counts per minute (cpm), minutes spent in moderate to vigorous activity (MVPA) and minutes of sedentary behaviour (msed) were derived from the accelerometer worn at age 12. Children were also examined, at age 10, using an autorefractor to estimate myopia. Social and parental factors were collected from pregnancy and physical measures of the child were recorded at age 12.
Results: 4880 children had valid PA and autorefraction data. In minimally adjusted models (age and gender) myopic children were less active than the other children: beta = -49.9 cpm (95% CI -73.5 to -26.4, p = <0.001). The myopic group spent less time in MVPA than the other children: beta = -3.2 minutes MVPA (95% CI -5.2 to -1.1, p = 0.003) and more time sedentary: beta = 15.8 minutes (95% CI 5.8 to 25.8, p = 0.002). The effect sizes were attenuated by adjustment for social and behavioural confounders although myopia status in the better (less myopic on autorefraction) eye remained strongly associated with cpm and MVPA but less so for sedentary behaviour: beta = -36.8 cpm (95% CI -67.8 to -5.8, p = 0.02), beta = -2.7 MVPA (95% CI -5.3 to -0.1, p = 0.04), beta = 10.1 msed (95% CI -2.9 to 23.1, p = 0.13).
Conclusion: Myopic children may be more at risk of having lower levels of PA than their non-myopic peers, although the difference was modest.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913228 | PMC |
http://dx.doi.org/10.1136/bjsm.2008.049288 | DOI Listing |
Background: Alzheimer's disease (AD) agitation is a distressing neuropsychiatric symptom characterized by excessive motor activity, verbal aggression, or physical aggression. Agitation is one of the causes of caregiver distress, increased morbidity and mortality, and early institutionalization in patients with AD. Current medications used for the management of agitation have modest efficacy and have substantial side effects.
View Article and Find Full Text PDFBackground: Alzheimer's disease is the most dreaded multifactorial neurological illness for which there is currently no known treatment. Although the exact cause of AD is still unknown, several factors related to lifestyle, genetics, and environment are known to have a significant role in the disease's development. Alzheimer's disease is characterized by neuronal loss, neurofibrillary tangles, and senile plaques.
View Article and Find Full Text PDFBackground: The LatAm-FINGERS trial marks a pioneering initiative as the first non-pharmacological clinical trial encompassing participants from 12 Latin American countries, including Argentina, Brazil, Bolivia, Chile, Colombia, Costa Rica, Ecuador, Dominican Republic, Mexico, Peru, Puerto Rico, and Uruguay. This initiative represents a significant advancement in promoting inclusivity and diversity in clinical trial recruitment, particularly in underserved populations.
Method: The LatAm-FINGERS trial is a multicenter randomized clinical trial evaluating a lifestyle intervention tailored for the Latin American population.
Alzheimers Dement
December 2024
National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.
Background: The effectiveness of multimodal lifestyle interventions to prevent dementia is being validated. Since a relatively long period (∼2 years) is required for manifesting an impact on cognitive function, the exploration of an alternative marker that exhibits changes within a comparatively brief duration, thereby prognosticating future alterations in cognitive function, is needed. The decline in gait function is associated with cognitive impairment and is also a predictor of future cognitive decline.
View Article and Find Full Text PDFBackground: Irisin is an exercise-induced myokine that elicits beneficial effects of exercise in fat, bone, and the brain. Previous work suggests that extracellular heat shock protein 90a (Hsp90a) mediates irisin-receptor interaction in bone and fat. Despite this, it remains unclear if Hsp90a is necessary for irisin signaling in the brain.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!